Bdpoma 4 mg Tablet

Bdpoma 4 mg Tablet contains pomalidomide, an oral immunomodulatory anticancer medicine. It is mainly used to treat multiple myeloma in eligible patients, usually in combination with other medicines. Pomalidomide helps control abnormal plasma cells and supports the immune response against cancer.

BUY NOW

Bdpoma 4 mg Tablet is prescribed under specialist supervision for patients with multiple myeloma who require pomalidomide-based treatment. Pomalidomide works through immunomodulatory effects that can inhibit the growth and survival of abnormal plasma cells. The capsule is generally taken orally according to the prescribed treatment cycle and may be taken with or without food. Regular monitoring of blood counts and other clinical parameters is important because treatment can cause significant hematological and other adverse effects.

Technical Specification

Specification Details
Active Ingredient Pomalidomide
Strength 4 mg
Dosage Form Capsule
Route of Administration Oral
Pack Size 21 Capsules
Manufacturer BDR Pharmaceuticals Internationals Pvt Ltd

Product Also Known As

Bdpoma 4 mg Capsule, Pomalidomide 4 mg Capsule, Bdpoma Pomalidomide Capsule, Pomalidomide Multiple Myeloma Capsule, Immunomodulatory Anticancer Capsule, Plasma Cell Cancer Treatment Capsule